Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

MANCUSO, Salvatrice
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.174
EU - Europa 4.236
AS - Asia 4.098
SA - Sud America 623
AF - Africa 102
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 18.248
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.056
SG - Singapore 1.555
RU - Federazione Russa 1.211
CN - Cina 1.018
IT - Italia 918
BR - Brasile 488
DE - Germania 448
HK - Hong Kong 416
FI - Finlandia 361
VN - Vietnam 346
PL - Polonia 257
UA - Ucraina 226
GB - Regno Unito 172
JP - Giappone 172
FR - Francia 168
IE - Irlanda 130
SE - Svezia 113
IN - India 111
BD - Bangladesh 83
KR - Corea 81
NL - Olanda 56
CA - Canada 51
IQ - Iraq 47
AR - Argentina 43
TR - Turchia 43
MX - Messico 38
RO - Romania 33
ES - Italia 29
PK - Pakistan 29
AT - Austria 28
IR - Iran 27
ID - Indonesia 24
ZA - Sudafrica 24
BE - Belgio 23
UZ - Uzbekistan 22
VE - Venezuela 21
SA - Arabia Saudita 20
UY - Uruguay 15
CO - Colombia 14
EC - Ecuador 14
MA - Marocco 14
CH - Svizzera 13
CI - Costa d'Avorio 13
CL - Cile 13
JO - Giordania 13
EG - Egitto 12
MY - Malesia 11
NP - Nepal 11
CZ - Repubblica Ceca 10
KE - Kenya 10
IL - Israele 9
PH - Filippine 9
PY - Paraguay 9
BG - Bulgaria 8
CR - Costa Rica 7
DZ - Algeria 7
EU - Europa 7
GR - Grecia 7
JM - Giamaica 7
LT - Lituania 7
AU - Australia 6
KZ - Kazakistan 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
LB - Libano 5
AL - Albania 4
AZ - Azerbaigian 4
BH - Bahrain 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
KG - Kirghizistan 4
OM - Oman 4
AO - Angola 3
BB - Barbados 3
DK - Danimarca 3
GH - Ghana 3
HR - Croazia 3
KW - Kuwait 3
PT - Portogallo 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
CY - Cipro 2
MM - Myanmar 2
PA - Panama 2
SR - Suriname 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 18.239
Salva come PNG Salva come JPEG
Città #
Ashburn 1.128
Fairfield 1.076
Singapore 978
Chandler 532
Woodbridge 500
Houston 490
Wilmington 441
San Jose 432
Hong Kong 401
Seattle 383
Cambridge 363
Secaucus 338
Ann Arbor 269
Zgierz 228
Beijing 211
Moscow 194
Council Bluffs 183
Palermo 162
Medford 160
Des Moines 153
Tokyo 151
Helsinki 146
Dublin 129
Los Angeles 128
Dallas 121
Santa Clara 115
Nanjing 106
Ho Chi Minh City 105
Lauterbourg 104
Altamura 103
Princeton 103
Frankfurt am Main 102
New York 100
Jacksonville 95
Hanoi 89
Dearborn 81
Hefei 81
The Dalles 81
Lawrence 74
Buffalo 67
San Diego 64
Rome 61
Milan 58
Boardman 56
Chicago 45
São Paulo 44
Tulsa 42
Ludwigshafen am Rhein 39
Columbus 37
Shenyang 36
Amsterdam 30
London 29
Orem 29
Hebei 28
Nanchang 27
Seoul 27
Tianjin 27
Brooklyn 23
Brussels 23
Changsha 22
Jinan 22
Ningbo 22
Phoenix 22
Atlanta 21
Chennai 21
Jiaxing 21
Guangzhou 20
Tashkent 19
Nuremberg 18
Zhengzhou 18
Baghdad 17
Poplar 17
Venice 17
Warsaw 17
Denver 16
Rio de Janeiro 16
Bremen 15
Da Nang 15
San Paolo di Civitate 15
Tehran 15
Kumar 14
Lappeenranta 14
Redwood City 14
Abidjan 13
Curitiba 13
Hangzhou 13
Montreal 13
Piscataway 13
Washington 13
Haiphong 12
Mumbai 12
Saint Petersburg 12
Shanghai 12
Stockholm 12
Toronto 12
Amman 11
Johannesburg 11
Montevideo 11
Vienna 11
Biên Hòa 9
Totale 12.059
Salva come PNG Salva come JPEG
Nome #
Absolute Lymphocyte Count Is Unrelated to Overall Survival in Newly Diagnosed Elderly Patients with Multiple Myeloma Treated with Immunomodulatory Drugs. 484
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL) 442
Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study 326
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 299
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 275
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system 269
Acquired haemophilia in cancer: A systematic and critical literature review 254
Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study. 248
Buffy coat-derived platelets cryopreserved using a new method: Results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia 248
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical hodgkin lymphoma and correlation with early FDG-PET assessment 231
Acquired Hemophilia A Associated with Venous Thrombosis and Very High Inhibitor Titer: A Challenging Scenario 230
T Cell Large Granular Lymphocytic Leukemia in Association with Sjógren's Syndrome 227
Combined Point of Care Tools Are Able to Improve Treatment Adherence and Health-Related Quality of Life in Patients with Severe Hemophilia: An Observational Prospective Study 221
Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies 215
Immunosenescence and lymphomagenesis 211
Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis 210
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL 210
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate 209
A Case of Fatal Drug Rash Eosinophilia and Systemic Symptoms from Allopurinol 203
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-one 202
Screening sierologico per l'infantum in soggetti HIV+ in area endemica Sicilia occidentale 200
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 198
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: A Fondazione Italiana Linfomi phase II study 198
Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study. 195
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 195
Screening sierologico per Leishmania infantum su donatori di sangue e HIV+ asintomatici residenti in area endemica [Serological screening for Leishmania infantum in asymptomatic blood donors and HIV+ patients living in an endemic area] 193
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. 193
Cardio-oncology in multiple myeloma: is it time for a specific focus? 191
Evaluation of Bone Marrow CD8+ tissue-Resident Memory T Cells in Multiple Myeloma 191
Genetic diversity of HIV-1 non-B strains in Sicily: Evidence of intersubtype recombinants by Sequence Analysis of gag, pol, and env genes 184
A novel methodology for large-scale phylogeny partition 181
DETECTION OF HIV TYPE 1 (HIV-1) NON-B SUBTYPES IN SICILY, ITALY 180
Comprehensive Geriatric Assessment is an essential tool to support treatment decisions in elderly patients with Diffuse Large B Cell Lymphoma: A prospective multicenter evaluation on 173 patients by the Lymphoma Italian Foundation (FIL) 177
Clinical history of thrombosis before diagnosis of overt myeloproliferative neoplasms in triple negative patients 177
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS 175
PNEUMOCYSTIS JIROVECI PNEUMONIA IN HEMATOLOGICAL PATIENTS: A SINGLE INSTITUTION EXPERIENCE 173
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors 173
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA. FINAL RESULTS OF A MULTICENTER STUDY 171
BENDAMUSTINE (B) IN COMBINATION WITH RITUXIMAB (R) FOR PATIENTS WITH RELAPSED/RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): AN ITALIAN MULTICENTRE RETROSPECTIVE STUDY 170
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 169
Cardiovascular risk factor in MPN patients 169
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep 168
Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association 167
Lymphomas and thyroid: Bridging the gap 163
"Long term anticoagulant treatment management in patients with portal vein thrombosis at high bleeding risk" 162
MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? 161
Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors 161
ABSOLUTE LYMPHOCYTE COUNT AS PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA 160
Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature 157
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas 152
BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS SALVAGE THERAPY FOR SPLENIC MARGINAL ZONE LYMPHOMA 152
CD200 ANTIGEN IN B-CELL DERIVED NEOPLASMS: EXPRESSION AND CLINICAL IMPACT IN 77 CONSECUTIVE PATIENTS OF A SINGLE ISTITUTION 152
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction 152
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 152
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-trifluoromethyl-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-one 149
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL). 149
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA 148
Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review. 147
Chronic myeloid leukemia as second malignancy; a retrospective multicentrico study 146
CANCER AS A PREDICTOR FOR INCREASED PERIPROCEDURAL BLEEDING DURING SURGERY OR PLATELET-INDUCED CHEMOTHERAPY IN CHRONICALLY ANTICOAGULATED PATIENTS 146
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting 146
Lymphonodal amyloidosis: case report 145
The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma 145
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010 143
Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: A cross-sectional analysis 140
Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials 139
INFEZIONE DA HIV E IMMIGRATI NEGLI ULTIMI CINQUE ANNI DI ATTIVITA' DEL NOSTRO CENTRO 139
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): Analysis of the incidence of newly acquired hepatitis B infection and syphilis 138
Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype 138
“Evidence of HIV-1 second-generation recombinant strains (SGRs) in Sicily: sequence analysis of gag, pol, and env genes.” 135
Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review 135
Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma 135
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration 134
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice 134
MOLECULAR EPIDEMIOLOGY OF HIV TYPE 1 (HIV-1) NON-B SUBTYPES IN SICILY 132
Dimagrimento e diarrea: oltre la "wasting syndrome" 131
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort 131
Paroxysmal nocturnal hemoglobinuria-like phenotype and thrombotic risk in several clinical disorders 131
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study 131
AIDS AND SURGICAL PATIENTS 130
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 130
Bone damage after chemotherapy for lymphoma: a real-world experience 130
Bendamustin in association with Rituximab (BR) in the treatment of patients with relapsed/refractory lymphoid neoplasm. A GISL retrospective study 127
PREDICTORS OF RESIDUAL VEIN THROMBOSIS AFTER CANCER-RELATED DEEP VEIN THROMBOSIS OF THE LOWER LIMBS 126
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe 126
Paroxysmal nocturnal haemoglobinuria: When delay in diagnosis and long therapy occurs 124
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 124
E' la pneumocistosi ancora presente in pazienti HIV positivi in epoca HAART? 123
Chronic myeloid leukemia as second malignancy; restrospective multicentric study 122
Functional In Vitro Studies Of Buffy Coat Pooled Platelets Cryopreserved In Dimethyl-Sulphoxide With a New System 119
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy 119
Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy 118
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations 118
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: Not All AIDS-defining conditions are created equal 116
Familial essential thrombocythemia: 6 cases from a mono‐institutional series 116
Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different? 114
RICERCA DI GIARDIA, CRYPTOSPORIDIUM E ISOSPORA IN SOGGETTI HIV POSITIVI 114
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia 114
Molecular epidemiology of HIV type 1 (HIV-1) non-B subtypes in SIcily 113
VEBEP REGIMEN IN PATIENTS (PTS) WITH HD AND HIV INFECTION(HD-HIV): FINAL RESULTS OF A PHASE II STUDY OF THE ITALIAN COOPERATIVE GROUP ON AIDS AND TUMORS (GICAT) 110
Totale 17.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.794
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021284 0 0 0 0 0 0 0 0 0 0 142 142
2021/20221.204 102 222 28 49 19 57 63 68 139 187 73 197
2022/20231.597 155 299 29 164 172 259 107 127 183 27 48 27
2023/2024737 29 103 61 103 55 139 76 24 6 19 18 104
2024/20251.916 57 96 74 177 92 58 132 149 154 208 268 451
2025/20267.512 552 655 372 534 735 1.045 1.094 756 630 859 280 0
Totale 18.801